We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Yourgene Health Plc | LSE:YGEN | London | Ordinary Share | GB00BN31ZD89 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.515 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
13/3/2019 10:23 | ... in summary??? | ikeadave | |
12/3/2019 15:22 | 2 x buy trades just gone through from 12.58pm at a premium,someone still accumulating and the mms will have to move up at some point,more than likely when the buyer as done,you'll see 😉 Edit my apologies the trades were from y'day (wish advfn would date their trades)one was cancelled and at that time it was a sell below bid. Doh | scotty1 | |
08/3/2019 12:47 | Twix instead of moaning all the time why not do something constructive like putting the interview and other comments in the header for any newcomers to see. | scotty1 | |
08/3/2019 12:31 | Were did i admit that?well you are in YGEN looks like you also got it wrong. | scotty1 | |
08/3/2019 12:28 | So you admit you were wrong. That's all I need lolTW gets it wrong regularly too | twix386 | |
08/3/2019 12:27 | Or are you telling me he came out if the blocks from the start with a price target for Q1 nap pick by April/easter. lol Not my recollection of his first unrevised Q1 nap tip being after end Q1, but subsequently April and easter got mentioned/added AFAIK. | twix386 | |
08/3/2019 12:26 | Twix you are just a moaner,sell up and move on perhaps investing/trading isn't for you😁 | scotty1 | |
08/3/2019 12:22 | Lol. He may have revised it to easter too at some point. You do know it was originally his q1 nap tip at price. Originally the clue was in the name Q1Revisions. Revisions. A TW speciality and I was being generous with 12! | twix386 | |
08/3/2019 12:08 | Nope wrong again twix he said by Easter,lets see now when is Easter oh yeah April.I do wish you would get facts right before you post. | scotty1 | |
08/3/2019 12:00 | TW slipping over Q1, as the deadline draws nearer and so far 20p does not.Now by April, why not by end March! | twix386 | |
08/3/2019 08:26 | I see the mms are still taking full advantage this morn on a 8k sell.Enter the buyer ? | scotty1 | |
07/3/2019 12:21 | Here's that link from twix386 save copy and pasting. | scotty1 | |
07/3/2019 11:35 | Well, he's sorted out the patent dispute and the debt pretty quickly .. If he can have the same effect on sales / new contracts, the numbers will surely be good going forward! He mentioned targeting another 30 countries on top of the 20 so far .... The current share price is crazy! | ikeadave | |
07/3/2019 10:56 | Nice find from LSEhttps://www.proac | twix386 | |
07/3/2019 10:12 | Seems Scotty bang in with the analysis. | frenchfry | |
07/3/2019 08:24 | Yep it really is timojelly and the mms are taking full advantage of the low volume,watch for the bigger buy trade come in as i still believe we have a buyer around these lvls and this is being worked for them,we will see 😉 | scotty1 | |
07/3/2019 08:14 | Bonkers 10p at this rate. | timojelly | |
05/3/2019 10:24 | Great find scotty1 | toyin | |
05/3/2019 07:24 | Atgenomix, Yourgene Bioscience Team on NGS Analysis Pipeline Mar 04, 2019 | staff reporter NEW YORK (GenomeWeb) – Taiwanese genomic informatics startup Atgenomix is combining its high-speed data analytics platform with hereditary and cancer mutation analysis workflows from Yourgene Bioscience Taiwan, the companies announced last week. Through this collaboration, Atgenomix and Yourgene look to offer a unified system for advanced whole-genome sequencing and whole-exome sequencing variant analysis. Specifically, they will build on the open-source Apache Spark analytics framework to link Yourgene's bioinformatics applications with Atgenomix's computing technology to create a "comprehensive clinical-grade WGS/WES analysis pipeline," the companies said. "Integrating our solutions will give customers the full spectrum of accelerated whole-genome and exome sequencing analysis with unrivaled bioinformatics expertise, advancing precision medicine from scientific research to clinical use," Atgenomix CEO Allen Chang said in a statement. "Yourgene's global presence also creates an opportunity for Atgenomix to move to the next level of product adoption worldwide." Atgenomix claims to accelerate workflows 10-fold compared to traditional genomic analysis processes by making even standard desktop computers more efficient in processing genome data. Yourgene Bioscience Taiwan is a unit of Manchester, UK-based molecular diagnostic company Yourgene Health, formerly known as Premaitha Health. Thermo Fisher Scientific purchased a 9 percent stake in Yourgene Health last month. | scotty1 | |
01/3/2019 10:09 | Yep a bit of luck there timojelly 😉 looking at the trades the buys are the bigger trades with the sells being the smaller,imo someone is still accumulating a few,could we see news next week,here's hoping 🤞 | scotty1 | |
01/3/2019 09:36 | You called the 'double bottom' scotty | timojelly | |
01/3/2019 09:25 | Offer price creeping up,could be more to come today 😉 | scotty1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions